160 related articles for article (PubMed ID: 15074900)
1. My place, your place, or a safer place: the intention among Montréal injecting drug users to use supervised injecting facilities.
Green TC; Hankins CA; Palmer D; Boivin JF; Platt R
Can J Public Health; 2004; 95(2):110-4. PubMed ID: 15074900
[TBL] [Abstract][Full Text] [Related]
2. The potential public health and community impacts of safer injecting facilities: evidence from a cohort of injection drug users.
Wood E; Kerr T; Spittal PM; Li K; Small W; Tyndall MW; Hogg RS; O'Shaughnessy MV; Schechter MT
J Acquir Immune Defic Syndr; 2003 Jan; 32(1):2-8. PubMed ID: 12514408
[TBL] [Abstract][Full Text] [Related]
3. Willingness to use a supervised injection facility among young adults who use prescription opioids non-medically: a cross-sectional study.
Bouvier BA; Elston B; Hadland SE; Green TC; Marshall BD
Harm Reduct J; 2017 Feb; 14(1):13. PubMed ID: 28219388
[TBL] [Abstract][Full Text] [Related]
4. Injection drug users' perceptions regarding use of a medically supervised safer injecting facility.
Petrar S; Kerr T; Tyndall MW; Zhang R; Montaner JS; Wood E
Addict Behav; 2007 May; 32(5):1088-93. PubMed ID: 16930849
[TBL] [Abstract][Full Text] [Related]
5. A micro-environmental intervention to reduce the harms associated with drug-related overdose: evidence from the evaluation of Vancouver's safer injection facility.
Kerr T; Small W; Moore D; Wood E
Int J Drug Policy; 2007 Jan; 18(1):37-45. PubMed ID: 17689342
[TBL] [Abstract][Full Text] [Related]
6. Self-reported changes in drug use behaviors and syringe disposal methods following the opening of a supervised injecting facility in Copenhagen, Denmark.
Kinnard EN; Howe CJ; Kerr T; Skjødt Hass V; Marshall BD
Harm Reduct J; 2014 Oct; 11(1):29. PubMed ID: 25352296
[TBL] [Abstract][Full Text] [Related]
7. Perceptions about supervised injection facilities among people who inject drugs in Philadelphia.
Harris RE; Richardson J; Frasso R; Anderson ED
Int J Drug Policy; 2018 Feb; 52():56-61. PubMed ID: 29241143
[TBL] [Abstract][Full Text] [Related]
8. Use of North America's first medically supervised safer injecting facility among HIV-positive injection drug users.
Reddon H; Wood E; Tyndall M; Lai C; Hogg R; Montaner J; Kerr T
AIDS Educ Prev; 2011 Oct; 23(5):412-22. PubMed ID: 22010805
[TBL] [Abstract][Full Text] [Related]
9. Supervised injection facility use and all-cause mortality among people who inject drugs in Vancouver, Canada: A cohort study.
Kennedy MC; Hayashi K; Milloy MJ; Wood E; Kerr T
PLoS Med; 2019 Nov; 16(11):e1002964. PubMed ID: 31770391
[TBL] [Abstract][Full Text] [Related]
10. The willingness of people who inject drugs in Boston to use a supervised injection facility.
León C; Cardoso L; Mackin S; Bock B; Gaeta JM
Subst Abus; 2018 Jan; 39(1):95-101. PubMed ID: 28799847
[TBL] [Abstract][Full Text] [Related]
11. The validity of reporting willingness to use a supervised injecting facility on subsequent program use among people who use injection drugs.
DeBeck K; Kerr T; Lai C; Buxton J; Montaner J; Wood E
Am J Drug Alcohol Abuse; 2012 Jan; 38(1):55-62. PubMed ID: 21834612
[TBL] [Abstract][Full Text] [Related]
12. The perspectives of injection drug users regarding safer injecting education delivered through a supervised injecting facility.
Fast D; Small W; Wood E; Kerr T
Harm Reduct J; 2008 Oct; 5():32. PubMed ID: 18957139
[TBL] [Abstract][Full Text] [Related]
13. Nurse-delivered safer injection education among a cohort of injection drug users: evidence from the evaluation of Vancouver's supervised injection facility.
Wood RA; Wood E; Lai C; Tyndall MW; Montaner JS; Kerr T
Int J Drug Policy; 2008 Jun; 19(3):183-8. PubMed ID: 18367389
[TBL] [Abstract][Full Text] [Related]
14. The impact of COVID-19 public health measures on attendance and overdose at supervised injecting facilities in Australia.
Roxburgh A; Livingston M; Dietze P; Nielsen S; Cogger S; Bartlett M; Day C; Latimer J; Jauncey M; Clark N
Public Health; 2023 Nov; 224():90-97. PubMed ID: 37742585
[TBL] [Abstract][Full Text] [Related]
15. Use of a medically supervised injection facility among street youth.
Hadland SE; DeBeck K; Kerr T; Nguyen P; Simo A; Montaner JS; Wood E
J Adolesc Health; 2014 Nov; 55(5):684-9. PubMed ID: 24925493
[TBL] [Abstract][Full Text] [Related]
16. Acceptability and design preferences of supervised injection services among people who inject drugs in a mid-sized Canadian City.
Mitra S; Rachlis B; Scheim A; Bardwell G; Rourke SB; Kerr T
Harm Reduct J; 2017 Jul; 14(1):46. PubMed ID: 28709471
[TBL] [Abstract][Full Text] [Related]
17. Potential use of safer injecting facilities among injection drug users in Vancouver's Downtown Eastside.
Kerr T; Wood E; Small D; Palepu A; Tyndall MW
CMAJ; 2003 Oct; 169(8):759-63. PubMed ID: 14557313
[TBL] [Abstract][Full Text] [Related]
18. Willingness to access an in-hospital supervised injection facility among hospitalized people who use illicit drugs.
Ti L; Buxton J; Harrison S; Dobrer S; Montaner J; Wood E; Kerr T
J Hosp Med; 2015 May; 10(5):301-6. PubMed ID: 25754871
[TBL] [Abstract][Full Text] [Related]
19. Ambivalence about supervised injection facilities among community stakeholders.
Strike C; Watson TM; Kolla G; Penn R; Bayoumi AM
Harm Reduct J; 2015 Aug; 12():26. PubMed ID: 26292715
[TBL] [Abstract][Full Text] [Related]
20. The impact of a supervised injecting facility on ambulance call-outs in Sydney, Australia.
Salmon AM; van Beek I; Amin J; Kaldor J; Maher L
Addiction; 2010 Apr; 105(4):676-83. PubMed ID: 20148794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
